These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25876778)

  • 41. Mouse models in the study of chronic lymphocytic leukemia pathogenesis and therapy.
    Simonetti G; Bertilaccio MT; Ghia P; Klein U
    Blood; 2014 Aug; 124(7):1010-9. PubMed ID: 25006127
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular pathogenesis of CLL and its evolution.
    Rodríguez D; Bretones G; Arango JR; Valdespino V; Campo E; Quesada V; López-Otín C
    Int J Hematol; 2015 Mar; 101(3):219-28. PubMed ID: 25630433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The genetic landscape of chronic lymphocytic leukemia].
    Marosvári D; Alpár D; Király AP; Rajnai H; Reiniger L; Bödör C
    Magy Onkol; 2016 Jun; 60(2):118-25. PubMed ID: 27275638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia.
    Lazarian G; Guièze R; Wu CJ
    J Clin Oncol; 2017 Mar; 35(9):984-993. PubMed ID: 28297623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia.
    Sun C; Chen YC; Martinez Zurita A; Baptista MJ; Pittaluga S; Liu D; Rosebrock D; Gohil SH; Saba NS; Davies-Hill T; Herman SEM; Getz G; Pirooznia M; Wu CJ; Wiestner A
    Blood Adv; 2023 Jan; 7(1):145-158. PubMed ID: 35358998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent advances in the pathogenesis and treatment of chronic lymphocytic leukemia.
    Efremov DG; Laurenti L
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(3):105-20. PubMed ID: 25725699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions.
    Puente XS; Jares P; Campo E
    Blood; 2018 May; 131(21):2283-2296. PubMed ID: 29666114
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic evolution in chronic lymphocytic leukaemia.
    Delgado J; Villamor N; López-Guillermo A; Campo E
    Best Pract Res Clin Haematol; 2016 Mar; 29(1):67-78. PubMed ID: 27742073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?
    Vaisitti T; Arruga F; Deaglio S
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29649100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development.
    Smith EN; Ghia EM; DeBoever CM; Rassenti LZ; Jepsen K; Yoon KA; Matsui H; Rozenzhak S; Alakus H; Shepard PJ; Dai Y; Khosroheidari M; Bina M; Gunderson KL; Messer K; Muthuswamy L; Hudson TJ; Harismendy O; Barrett CL; Jamieson CH; Carson DA; Kipps TJ; Frazer KA
    Blood Cancer J; 2015 Apr; 5(4):e303. PubMed ID: 25860294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic lymphocytic leukaemia genomics and the precision medicine era.
    Ghamlouch H; Nguyen-Khac F; Bernard OA
    Br J Haematol; 2017 Sep; 178(6):852-870. PubMed ID: 28444740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genomic Instability and Clonal Evolution in Chronic Lymphocytic Leukemia: Clinical Relevance.
    Condoluci A; Rossi D
    J Natl Compr Canc Netw; 2020 Dec; 19(2):227-233. PubMed ID: 33383567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia.
    Ojha J; Ayres J; Secreto C; Tschumper R; Rabe K; Van Dyke D; Slager S; Shanafelt T; Fonseca R; Kay NE; Braggio E
    Blood; 2015 Jan; 125(3):492-8. PubMed ID: 25377784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of the tumor microenvironment in CLL pathogenesis.
    Vom Stein AF; Hallek M; Nguyen PH
    Semin Hematol; 2024 Jun; 61(3):142-154. PubMed ID: 38220499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The tumor microenvironment shapes hallmarks of mature B-cell malignancies.
    Shain KH; Dalton WS; Tao J
    Oncogene; 2015 Sep; 34(36):4673-82. PubMed ID: 25639873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution.
    Sutton LA; Rosenquist R
    Haematologica; 2015 Jan; 100(1):7-16. PubMed ID: 25552678
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The molecular pathogenesis of chronic lymphocytic leukaemia.
    Fabbri G; Dalla-Favera R
    Nat Rev Cancer; 2016 Mar; 16(3):145-62. PubMed ID: 26911189
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutations driving CLL and their evolution in progression and relapse.
    Landau DA; Tausch E; Taylor-Weiner AN; Stewart C; Reiter JG; Bahlo J; Kluth S; Bozic I; Lawrence M; Böttcher S; Carter SL; Cibulskis K; Mertens D; Sougnez CL; Rosenberg M; Hess JM; Edelmann J; Kless S; Kneba M; Ritgen M; Fink A; Fischer K; Gabriel S; Lander ES; Nowak MA; Döhner H; Hallek M; Neuberg D; Getz G; Stilgenbauer S; Wu CJ
    Nature; 2015 Oct; 526(7574):525-30. PubMed ID: 26466571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencing.
    Doménech E; Gómez-López G; Gzlez-Peña D; López M; Herreros B; Menezes J; Gómez-Lozano N; Carro A; Graña O; Pisano DG; Domínguez O; García-Marco JA; Piris MA; Sánchez-Beato M
    PLoS One; 2012; 7(6):e38158. PubMed ID: 22675518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies.
    Delgado J; Nadeu F; Colomer D; Campo E
    Haematologica; 2020 Sep; 105(9):2205-2217. PubMed ID: 33054046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.